Related Experiment Videos
Identification of an Epstein-Barr virus-coded thymidine kinase
The EMBO Journal
|August 1, 1986
Summary
Researchers identified Epstein-Barr virus (EBV)-coded thymidine kinase (TK) in transformed mammalian cells. This EBV TK enzyme shows homology to herpes simplex virus TK and is encoded by the BXLF1 gene.
Area of Science:
- Virology
- Molecular Biology
- Biochemistry
Background:
- Epstein-Barr virus (EBV) is a human herpesvirus implicated in various diseases.
- Thymidine kinase (TK) is a crucial enzyme in DNA synthesis and a target for antiviral therapies.
- The existence and function of an EBV-coded TK were previously unconfirmed.
Purpose of the Study:
- To demonstrate the presence and activity of an Epstein-Barr virus (EBV)-coded thymidine kinase (TK).
- To identify the specific EBV DNA sequences responsible for encoding the TK activity.
- To characterize the EBV TK protein and compare it to known viral TKs.
Main Methods:
- Biochemical transformation of mammalian cell lines using EBV virions or EBV DNA fragments.
- Analysis of transformed cell lines for EBV DNA presence, gene expression, and TK activity.
- Complementation assays using bacterial strains deficient in TK activity.
- Antigenic cross-reactivity tests and amino acid sequence comparisons.
Main Results:
- TK-positive mammalian cell lines were successfully generated, containing EBV DNA and expressing EBV sequences.
- A functional TK activity was detected in the transformed cell lines.
- The EBV TK gene was identified as the BXLF1 open reading frame.
- The EBV TK protein exhibited antigenic cross-reactivity with herpes simplex virus (HSV) TK and showed significant amino acid sequence homology to HSV-1 TK.
Conclusions:
- The study provides definitive evidence for an Epstein-Barr virus (EBV)-coded thymidine kinase (TK).
- The BXLF1 open reading frame encodes the EBV TK, which shares functional and structural similarities with HSV TK.
- This finding has implications for understanding EBV replication and developing targeted antiviral strategies.